Mara Renewables Corp. plans to invest in expanding its microalgae portfolio.
Mara Renewables Corp. (Dartmouth, NS, Canada), a company that creates algae-based nutritional and nutraceutical ingredients via fermentation, announced it recently raised $39.5 million in growth equity. It plans to invest in expanding its microalgae portfolio.
Mara produces algae ingredients through fermentation. In a press release, it says, “By going straight to the source, Mara is able to extract immense potential from marine plant life sustainably grown ashore, harnessing the power of the ocean without harvesting its resources.” For instance, in 2021, the company said it supplied enough DHA-rich fatty acids to the supplement, food, and beverage industries “to offset an estimated 7.36 billion fish (anchovy). “
“Mara is very excited to finalize our growth capital phase,” said Arturo Ania, CEO of Mara, in a press release. “This new investment will allow Mara to continue our aggressive growth trajectory and further expand new R&D initiatives into commercial products. We are certain that the expertise added around our investor and board table will allow us to continue our growth phase and expand our omega-3, protein, and other ingredient platforms to become world-changing solutions.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.